Connor, Clark & Lunn Investment Management (CC&L)’s Inovio Pharmaceuticals INO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,345
| Closed | -$49K | – | 1315 |
|
|
2022
Q3 | $49K | Buy |
+2,345
| New | +$49K | ﹤0.01% | 1067 |
|
|
2018
Q4 | – | Sell |
-7,222
| Closed | -$482K | – | 992 |
|
|
2018
Q3 | $482K | Sell |
7,222
-1,213
| -14% | -$81K | ﹤0.01% | 710 |
|
|
2018
Q2 | $397K | Buy |
8,435
+2,818
| +50% | +$133K | ﹤0.01% | 817 |
|
|
2018
Q1 | $317K | Buy |
+5,617
| New | +$317K | ﹤0.01% | 613 |
|
|
2016
Q1 | – | Sell |
-2,367
| Closed | -$191K | – | 867 |
|
|
2015
Q4 | $191K | Buy |
+2,367
| New | +$191K | ﹤0.01% | 708 |
|